European Partnerships in Health Research are announcing transnational calls for proposals for 2027. Research teams from the Czech Republic are also eligible to participate in these international calls. The Ministry of Health provides support to Czech applicants through the AZV ČR. The national budget allocation for each of the listed calls is 500 000 EUR. Preliminary proposals are to be submitted from mid-January through early February 2027.
Five European health partnerships are launching transnational calls for 2027:
- The ERA4Health and PerMed calls have been open since the fall, and we have reported on them previously.
- THCS opened its call for proposals on November 16.
- The OH AMR partnership call for proposals opens today, November 18, 2026.
- The ERDERA call will open on December 1, 2026.
Projects are submitted by international consortia, and each partner applies for funding from the funding agency in their own country. The selection process takes place in two rounds: first, pre-proposals are submitted, and selected applicants then submit full proposals.
The following conditions apply to Czech applicants in all calls for proposals:
- the national allocation is 500,000 EUR per call,
- a project may last no longer than 3 years (36 months),
- In addition to transnational rules, projects must also meet the conditions of Subprogram 3: European Partnerships in the Field of Health,
- Eligible applicants: research organizations, businesses, and patient organizations.
The AZV ČR publishes the national conditions for the remaining calls on its website on the date of their announcement.
For quick reference, we have prepared an overview of all five calls in PDF format. On each page, you will find the focus of the calls, consortium requirements, schedules, and dates for information sessions. Download the overview of calls (PDF).
ERA4Health – Multi-national Investigator-Initiated Clinical Studies (IICS4all 2027)
Focus: International, investigator-initiated, pragmatic, randomized Phase III clinical trials focused on cardiovascular, metabolic, autoimmune, and noncommunicable respiratory diseases.
Consortium: Partners from 3 to 5 countries (up to 6 if Slovakia is included), with at least 2 from among the two EU countries or countries associated with the Horizon Europe program.
Deadlines: preliminary proposals by January 14, 2027 (12:00 p.m.), full proposals by June 14, 2027 (12:00 p.m.).
PerMed – Cell and Gene Therapy for Personalized Medicine (CGT4PM2027)
Focus: Development and validation of innovative cell and gene therapy approaches in personalized medicine, targeting all disease areas.
Consortium: 3 to 6 partners from 3 different countries + mandatory inclusion of at least one early-career researcher as the principal investigator.
Deadlines: preliminary proposals by January 20, 2027 (2:00 p.m.), full proposals by May 25, 2027 (2:00 p.m).
THCS – Transforming the Health and Care Workforce for Sustainable and Resilient Systems
Focus: Implementing best practices: recruiting, training, and retaining health and care workers.
Consortium: 3 to 9 partners from at least 3 countries, with no more than 2 from any one country + mandatory involvement of stakeholders from the field, e.g., from patient organizations, municipalities, or schools.
Deadlines: preliminary proposals by January 21, 2027 (2:00 p.m.), full proposals by June 24, 2027 (2:00 p.m.).
OH AMR – Understand, Model, and Stop AMR Transmission
Focus: Prevention of the emergence and spread of antimicrobial resistance through a One Health approach: modeling transmission, the role of commensal microorganisms, and reducing resistance in the environment. Czech funding is intended solely for the field of human health.
Consortium: 3 to 6 partners from at least 3 different countries, with a maximum of 2 from a single institution. With a partner from the Czech Republic (an under-represented country), up to 7 members.
Deadlines: preliminary proposals by February 1, 2027; full proposals by June 23, 2027.
ERDERA – Support for collaborative research on recently identified rare diseases
Focus: Research in the field of recently identified rare diseases that have not yet been sufficiently studied scientifically.
Consortium: 3 to 6 partners (up to 8 in exceptional cases) from at least 3 countries, with no more than 2 from any one country + involvement of patient organizations.
Deadlines: call for proposals on December 1, 2026; preliminary proposals due by February 1, 2027; full proposals due by June 24, 2027.
AZV Czech Republic Information Days
In connection with the newly announced calls for proposals from the European partnerships ERA4Health and PerMed, as well as the upcoming calls for proposals from the THCS and OH AMR, and ERDERA, the Czech Health Research Agency (AZV ČR) is organizing a series of informational webinars. The webinars are intended primarily for the scientific community and project managers interested in participating in transnational research projects in the field of health. Participation must be confirmed by email at partnerstvi@azvcr.cz no later than two business days in advance.
More information and registration for individual webinars are available HERE.
International Partnership Information Days
- OH AMR: November 25, 2026, 1:30 p.m. to 3:30 p.m. (registration)
- THCS: December 2, 2026, 2:30 p.m. to 4:30 p.m. (registration)
- PerMed: December 3, 2026, 3:00 PM to 5:00 PM (registration)
- ERDERA: December 14, 2026, 3:00 PM to 4:00 PM (registration)
If you are interested in a consultation or support with preparing and submitting a project application, please contact Project Services at Palacký University in Olomouc. We will be happy to provide you with methodological and administrative support.
The AZV ČR / MZČR agenda falls under the jurisdiction of: Mgr. Pavla Tresterová
pavla.tresterova@upol.cz
58 563 1419 | 774 709 087